Aortic regurgitation in 2026
Sponsored by JenaValve Technology
TAVI
Symposium
JenaValve Technology
Room 251
Watch this session if you want
- To understand how to diagnosis and optimie the treatment of aortic regurgitation (AR) and help improve patient care of this undertreated disease
- To learn about and observe cases featuring the JenaValve Trilogy System, the only CE mark-approved device for treating both severe aortic regurgitation and aortic stenosis
- To learn about the future of TAVI for aortic regurgitation and what may come next
















